Skip to content

Drug interactions

Letermovir + Ramelteon

Severity: Minor

Letermovir and Ramelteon: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir is a moderate CYP3A4 inhibitor and may raise ramelteon exposure modestly. Ramelteon is mainly metabolized by CYP1A2, so the effect is expected to be limited, but increased next-day drowsiness is possible.

What this interaction means in plain words

Letermovir and Ramelteon have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Letermovir belongs to Anti Virals; Ramelteon belongs to Central Nervous System.

Evidence level: Low

Why it happens

Letermovir inhibits CYP3A4, a minor metabolic pathway for ramelteon.

What to do

No routine dose change is needed; ask the patient about excessive daytime sedation or dizziness and reduce the ramelteon dose if these occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letermovir and Ramelteon, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letermovir with Ramelteon?

MediHelp rates the interaction as minor. Letermovir and Ramelteon have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir is a moderate CYP3A4 inhibitor and may raise ramelteon exposure modestly. Ramelteon is mainly metabolized by CYP1A2, so the effect is expected to be limited, but increased next-day drowsiness is possible.

How serious is the interaction between Letermovir and Ramelteon?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; ask the patient about excessive daytime sedation or dizziness and reduce the ramelteon dose if these occur.

What other medicines interact with Ramelteon?

MediHelp also lists interactions of Ramelteon with, for example, Calcium / magnesium / potassium / sodium oxybates, Fluvoxamine, Sodium oxybate. The full list is on the Ramelteon page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in